Page last updated: 2024-09-03

hoe 694 and Hyperlipoproteinemia Type II

hoe 694 has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assmann, G; Kehrel, B; Nofer, JR; Seedorf, U; Tepel, M; Walter, M; Wierwille, S; Zidek, W	1

Other Studies

1 other study(ies) available for hoe 694 and Hyperlipoproteinemia Type II

Article	Year
Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation, 1997, Mar-18, Volume: 95, Issue:6 Topics: Adult; Antigens, CD; Binding Sites; Blood Platelets; Guanidines; Humans; Hydrogen-Ion Concentration; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Oxidation-Reduction; P-Selectin; Phosphatidylinositols; Platelet Aggregation; Platelet Membrane Glycoproteins; Propionates; Prostaglandins; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetraspanin 30; Thrombin; Type C Phospholipases	1997

Article

Year

Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.

Circulation, 1997, Mar-18, Volume: 95, Issue:6

Topics: Adult; Antigens, CD; Binding Sites; Blood Platelets; Guanidines; Humans; Hydrogen-Ion Concentration; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Oxidation-Reduction; P-Selectin; Phosphatidylinositols; Platelet Aggregation; Platelet Membrane Glycoproteins; Propionates; Prostaglandins; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetraspanin 30; Thrombin; Type C Phospholipases

1997